Clinical Trial Update: Safety and Preliminary Effectiveness Study of Mesenchymal Stem Cells, HeXell-2020, in Patients With Stable Coronary Artery Disease [Phase 1, Phase 2]

View source ↗

Summary

This is a Phase 1/2 safety and preliminary effectiveness study of HeXell-2020 mesenchymal stem cells in patients with stable coronary artery disease; the trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• HeXell-2020 Mesenchymal Stem Cells (Mesenchymal stem cells)

Snippet

Sponsor: Hexun Biosciences Co., LTD. | Conditions: Coronary Artery Disease | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING